For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
...in the Health
Keep up to date with what's new in the Health Professionals section of our website. To keep up to date with everything new at NPS, go to What's new at NPS
2012-02-01 00:00:00
Case study 72: Management of rhinosinusitis
(Professional activity - Case study)
Jessica, a 26-year-old student, presents to you complaining of a 4 day history of coloured nasal discharge, headache, lethargy and sneezing.
2012-01-16 00:00:00
NPS RADAR January 2012
(Professional publication - NPS RADAR - Complete issue)
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
2012-01-16 00:00:00
Apixaban (Eliquis) for preventing venous thromboembolism after knee or hip replacement surgery
(Professional publication - NPS RADAR - Brief item)
Information about Apixaban (Eliquis), listed on the PBS from 1 January 2012 for preventing venous thromboembolism after hip or knee replacement surgery.
2012-01-12 00:00:00
Case study 70 report: Antipsychotics
(Professional activity - Case study report)
This case study focused on management of schizophrenia, stable for the last 6 months on risperidone 5 mg/day, in 28-year-old Emily.
2012-01-05 00:00:00
Nurse Update January 2012
(Professional publication - Nurse Update)
This issue of Nurse Update talks about NPS's support of the TGA cancelling 4 pain relief medicines, issues relating to taking medicines during pregnancy, resources to help patients decide between different medicine brands and the new features to NPS's awarding winning Medicines List iPhone app
2011-12-01 00:00:00
Oxycodone-with-naloxone controlled-release tablets (Targin) for chronic severe pain
(Professional publication - NPS RADAR - Review)
Information about oxycodone-with-naloxone controlled-release (CR) tablets (Targin) for chronic severe pain. The tablets provide equivalent analgesia to that of oxycodone CR tablets, with reduced opioid-induced constipation.
2011-12-01 00:00:00
Asenapine (Saphris) for schizophrenia or bipolar I disorder (acute mania or maintenance)
(Professional publication - NPS RADAR - Review)
Information about asenapine sublingual wafers (Saphris) for schizophrenia and acute and maintenance treatment of manic and mixed episodes in bipolar I disorder. Asenapine has a similar spectrum of benefits and harms to that of other antipsychotics.
2011-12-01 00:00:00
Ticagrelor (Brilinta) for acute coronary syndrome
(Professional publication - NPS RADAR - Review)
Ticagrelor (Brilinta) and aspirin reduces the incidence of vascular deaths and myocardial infarctions more than clopidogrel and aspirin, but this must be weighed against an increased risk of adverse events.
2011-12-01 00:00:00
NPS RADAR December 2011
(Professional publication - NPS RADAR - Complete issue)
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Date published: 2008-02-21 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.